Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Obrad Kokanovic

Interventional Cardiology Hoffman Estates, IL Medical Doctor

NPI 1528358660 CMS profile 463851

2359 Hassell Rd, Hoffman Estates, IL 60169

Open in the dashboard

General payments

$45,627

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Obrad Kokanovic of Hoffman Estates, IL is reported in the CMS Open Payments database as having received $45,627 across 84 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,058 44
2024 General $1,589 17
2023 General $286 10
2022 General $378 8
2021 General $20 1
2019 General $296 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Obrad Kokanovic
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Obrad Kokanovic were reported at $43,058. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Obrad Kokanovic Interventional Cardiology median Middle half National median
2019 $296 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $20 $677 $233–$1,827 $132
2022 $378 $978 $333–$2,724 $149
2023 $286 $1,136 $382–$2,986 $160
2024 $1,589 $1,181 $395–$3,326 $164
2025 $43,058 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $39,757 29 payments
  2. Edwards Lifesciences Corporation $2,915 25 payments
  3. Boston Scientific Corporation $1,246 7 payments
  4. W. L. Gore & Associates, Inc. $524 2 payments
  5. Medtronic, Inc. $436 4 payments
  6. E.R. Squibb & Sons, L.L.C. $161 6 payments
  7. Acist Medical Systems, Inc. $146 1 payment
  8. Janssen Scientific Affairs, LLC $123 1 payment
  9. Pfizer Inc. $110 1 payment
  10. Medicure Pharma Inc. $70 1 payment
  11. Other $139 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $37,500 1 payment
  2. Travel and Lodging $5,297 24 payments
  3. Food and Beverage $2,829 58 payments
  4. Education $1 1 payment
Products named General payments · program years 2019–2025
  1. MITRACLIP Structural Heart $37,500 1 payment
  2. SAPIEN 3 Ultra RESILIA $1,089 13 payments
  3. TRICLIP $1,069 13 payments
  4. MITRACLIP Vascular $1,047 12 payments
  5. PASCAL $1,026 7 payments
  6. VersaCross Connect LAAC Access Solution $984 4 payments
  7. GORE CARDIOFORM Septal Occluder $524 2 payments
  8. COREVALVE EVOLUT R $363 2 payments
  9. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $180 2 payments
  10. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $174 1 payment
  11. Other $1,298 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

39

Median for Interventional Cardiology: 2,236

Drug cost

$16,363

Median for Interventional Cardiology: $380,412

Branded share of claims

66.7%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 26 $16,329
Spironolactone Generic 13 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record